Q1 2025 LivaNova PLC Earnings Call Transcript

May 7, 2025 / 12:00 PM GMT

Release Date Price: €30.8 (-3.14%)

Transcript 10-Q8-K

Key Points

Positve

LivaNova PLC (LIVN) achieved 10% organic revenue growth in Q1 2025, marking the 8th time in the past 9 quarters with double-digit growth.
The Osprey trial for obstructive sleep apnea showed a 65% responder rate at 12 months, validating the potential of their neurostimulation therapy.
Cardiopulmonary segment revenue increased by 15% year-over-year, with heart-lung machine revenue growing approximately 30%.
Regulatory approval for the Essence heart-lung machine in China, the second-largest market after the US, was received ahead of schedule.
The company has a strong cash position, with a cash balance of $738 million, up from $429 million at the end of 2024, allowing for strategic investments and debt repayment.

Negative

LivaNova PLC (LIVN) recorded a $360 million liability related to an Italian Supreme Court decision, impacting financial results.
The US epilepsy business experienced procedure deferrals due to a voluntary field safety notification, impacting revenue by less than $2 million.
Adjusted gross margin decreased to 70% from 71% in the prior year, driven by unfavorable product mix and inflationary headwinds.
The company faces an uncertain tariff environment, with an estimated impact of less than $5 million on adjusted operating income for the year.
Adjusted R&D expenses decreased, reflecting investment optimization, but this could impact future innovation and development.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LIVN.OQ - LivaNova PLC
Q1 2025 LivaNova PLC Earnings Call
May 07, 2025 / 12:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, ladies and gentlemen, and welcome to the Lenova PLC first quarter 2025 earnings conference call.

My name is Emily and I'll be coordinating your call today.

As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Miss Brianna Gotlin, Ivanova's Vice President of investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and welcome to our conference call and webcast discussing Ivanova's financial results for the first quarter of 2025.

Joining me on today's call

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.